MT-4 |
| Catalog No.GC36660 |
MT-4 bloque le complexe TG2/FN À l'interface entre les cellules cancéreuses et la niche tumorale. MT-4 inhibe l'adhérence des cellules cancéreuses de l'ovaire (CO) au péritoine.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2327925-35-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MT-4 blocks the TG2/FN complex at the interface between cancer cells and the tumor niche. MT-4 inhibits the adhesion of ovarian cancer (OC) cells to the peritoneum[1]. TG2/FN complex[1].
Pre-treatment with MT4 sensitizes ovarian cancer (OC) cells to traditional anticancer drug[1].
[1]. Sima LE, et al. Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin. Mol Cancer Ther. 2019 Jun;18(6):1057-1068.
Average Rating: 5 (Based on Reviews and 19 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *